Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2 results

Filters applied: . Clear all
Page 1
Vemurafenib and ipilimumab: new agents for metastatic melanoma.
Banaszynski M, Kolesar JM. Banaszynski M, et al. Among authors: kolesar jm. Am J Health Syst Pharm. 2013 Jul 15;70(14):1205-10. doi: 10.2146/ajhp120260. Am J Health Syst Pharm. 2013. PMID: 23820456 Review.
Disadvantages of vemurafenib include the short duration of response; significant skin toxicities, including skin cancers and severe photosensitivity; the need for long-term daily administration; and the potential for drug interactions. ...
Disadvantages of vemurafenib include the short duration of response; significant skin toxicities, including skin cancers and severe photosen …
Exemestane for primary prevention of breast cancer in postmenopausal women.
Zhang Y, Simondsen K, Kolesar JM. Zhang Y, et al. Among authors: kolesar jm. Am J Health Syst Pharm. 2012 Aug 15;69(16):1384-8. doi: 10.2146/ajhp110585. Am J Health Syst Pharm. 2012. PMID: 22855103
Ongoing clinical trials with other aromatase inhibitors are underway to evaluate the benefits and long-term skeletal risks. CONCLUSION: Exemestane 25 mg daily taken for at least three years is a new option for the prevention of breast cancer in high-risk postmenopausal wom …
Ongoing clinical trials with other aromatase inhibitors are underway to evaluate the benefits and long-term skeletal risks. CONCLUSIO …